Author: Publisher:
ISBN:
Category :
Languages : en
Pages : 690
Book Description
The Monthly Magazine
Author: National Library of Medicine Catalog
Author: National Library of Medicine (U.S.)Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 910
Book Description
The Medical and Physical Journal
Author: Catalogus Librorum Impressorum Bibliothecae Bodleianae in Academia Oxoniensi B. Bandinel
Author: Catalogus Librorum Impressorum Bibliothecae Bodleianae in Academia Oxoniensi
Author: Bulkeley BandinelPublisher:
ISBN:
Category : Library catalogs
Languages : en
Pages : 936
Book Description
The London Medical and Physical Journal
Author: Medico-chirurgical Review and Journal of Practical Medicine
Author: London Medical and Physical Journal
Author: Catalogus Librorum Impressorum Bibliothecae Bodleianae in Academia Oxoniensi
Author: Bodleian LibraryPublisher:
ISBN:
Category : Library catalogs
Languages : en
Pages : 932
Book Description
Pain Management and the Opioid Epidemic
Author: National Academies of Sciences, Engineering, and MedicinePublisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483
Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.